Abbott Laboratories (ABT)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 41,950,000 41,217,000 40,725,000 40,326,000 40,109,000 39,959,000 40,226,000 41,505,000 43,653,000 45,030,000 45,548,000 44,514,000 43,075,000 42,308,000 40,233,000 37,338,000 34,608,000 32,221,000 31,444,000 32,095,000
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $41,950,000K ÷ $—K
= —

The receivables turnover ratio for Abbott Laboratories is not available for the periods specified (March 31, 2020 to December 31, 2024) in the provided data. The receivables turnover ratio measures how efficiently a company is collecting payments from its customers. A higher ratio indicates that the company is converting its accounts receivable into cash quickly, while a lower ratio may suggest potential issues with collecting payments on time. Without the specific data points, it is not possible to assess Abbott Laboratories' performance in managing its accounts receivable turnover over the specified periods. It is recommended to obtain the relevant financial figures to calculate the receivables turnover ratio and analyze the trend for a comprehensive assessment of the company's receivables management efficiency.


See also:

Abbott Laboratories Receivables Turnover (Quarterly Data)